154 related articles for article (PubMed ID: 2054612)
1. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
Carson KA; Geula C; Mesulam MM
Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
[TBL] [Abstract][Full Text] [Related]
2. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
3. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
4. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.
Gomez-Ramos P; Mufson EJ; Moran MA
Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
9. Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
Darvesh S; Reid GA
Chem Biol Interact; 2016 Nov; 259(Pt B):307-312. PubMed ID: 27091549
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Ruberg M; Rieger F; Villageois A; Bonnet AM; Agid Y
Brain Res; 1986 Jan; 362(1):83-91. PubMed ID: 3942870
[TBL] [Abstract][Full Text] [Related]
11. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
Mesulam M; Guillozet A; Shaw P; Quinn B
Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
Kalaria RN; Kroon SN; Grahovac I; Perry G
Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
[TBL] [Abstract][Full Text] [Related]
13. Changes in brain cholinesterases in senile dementia of Alzheimer type.
Perry EK; Perry RH; Blessed G; Tomlinson BE
Neuropathol Appl Neurobiol; 1978; 4(4):273-7. PubMed ID: 703927
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase in the life cycle of amyloid plaques.
Guillozet AL; Smiley JF; Mash DC; Mesulam MM
Ann Neurol; 1997 Dec; 42(6):909-18. PubMed ID: 9403484
[TBL] [Abstract][Full Text] [Related]
15. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
Lehmann DJ; Nagy Z; Litchfield S; Borja MC; Smith AD
Hum Genet; 2000 Apr; 106(4):447-52. PubMed ID: 10830913
[TBL] [Abstract][Full Text] [Related]
16. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
Schätz CR; Geula C; Mesulam M
Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
Darvesh S
Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
19. No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism.
Hatanpää K; Chandrasekaran K; Brady DR; Rapoport SI
Brain Res Mol Brain Res; 1998 Aug; 59(1):13-21. PubMed ID: 9729244
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons.
Mesulam MM; Brimijoin S; Geula C
Neurobiol Aging; 1994; 15(5):615-9. PubMed ID: 7824053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
